Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smoking May Trigger Pancreatic Cancer

By Biotechdaily staff writers
Posted on 22 Nov 2004
Tobacco may serve as an environmental trigger for patients with an inherited genetic predispostion to pancreatic cancer, according to a new study in the December 15, 2004, issue of Cancer.

Pancreatic cancer is rare and poorly studied. More...
It is known that it is an aggressive cancer, with a five-year survival of only 4%. A small percentage of patients with pancreatic cancer have first-degree relatives with pancreatic cancer. Smoking has been identified as the single most-important risk factor in familial pancreatic adenocarcinoma (FPAC), but the genetic component of the disease has remained a mystery.

The study consisted of a retrospective review of 826 patients with pancreatic cancer. Researchers found that 30 of these had the familial form. This group tended to be younger and to have a history of smoking. Specifically, about 87% of FPAC patients smoked, while only 66% of those with sporadic pancreatic cancer smoked.

"Patients with a family history of pancreatic cancer must be strongly counseled against smoking, and smokers with a family history of pancreatic cancer should be informed of their increased risk and offered enrollment into a smoking cessation program,” concluded the authors of the study, led by Ted A. James, M.D., of the Roswell Park Cancer Institute in Buffalo (NY, USA

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.